Pre-Close Trading Update

RNS Number : 1298Z

Genus PLC

16 July 2008

 



For Immediate Release                                                                     16 July 2008   

GENUS plc

('Genus' or 'the Company')

Pre-Close Trading Update

Genus, a leading global animal genetics company, today issues an update on trading for the six months to 30 June 2008.

Genus has continued to trade in line with the Board's expectations and has successfully offset the impact of exceptionally high global animal feed prices with the increased international spread of its business and improved efficiencies. The Board therefore remains confident in the outlook for the future. 

Genus will announce its Preliminary Results on 16 September 2008.

For further information please contact:

Genus plc                                            Tel: [phone]

Richard Wood, Chief Executive

Martin Boden, Finance Director

Buchanan Communications                Tel: [phone]

Charles Ryland

Suzanne Brocks

This announcement is available on the Genus website, www.genusplc.com

About Genus:

Genus sells added value products for livestock farming and food producers by creating advances to animal breeding through biotechnology. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors.

Genus' worldwide sales are made in seventy countries under the trade marks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers use Genus genetics in their herds to produce offspring with greater production efficiency, milk and meat output and quality. These offspring are used to supply the global dairy and meat supply chains.

Genus' competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and the Group's global production and distribution network.

Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA. 

 

END

 

 

TSTEALXSFLSPEFE